Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07643792
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture SurgeryPeking University First HospitalNot Yet RecruitingPhase 4
NCT07643792Not Yet Recruiting
Phase 4
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture...Peking University First H...
NCT07645573
18F-FTHA IMAGING OF THE INTESTINAL AND CENTRAL LYMPHATIC SYSTEMUniversity of PennsylvaniaRecruitingEarly Phase 1
NCT07645573Recruiting
Early Phase 1
18F-FTHA IMAGING OF THE INTESTINAL AND CENTRAL LYMPHATIC SYSTEMUniversity of Pennsylvani...
NCT07646340
Long-term Pelvic Floor and Sexual Health After Obstetric Anal Sphincter Injury in FinlandTampere University HospitalEnrolling By Invitation
NCT07646340Enrolling By Invitation
—
Long-term Pelvic Floor and Sexual Health After Obstetric Anal Sphincter Injury i...Tampere University Hospit...
NCT07646288
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After LobectomyHacettepe UniversityRecruitingNot Applicable
NCT07646288Recruiting
Not Applicable
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobe...Hacettepe University
NCT07645287
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1Gilead SciencesNot Yet RecruitingPhase 2
NCT07645287Not Yet Recruiting
Phase 2
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologica...Gilead Sciences
NCT07645651
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic CancerCarrick Therapeutics LimitedNot Yet RecruitingPhase 1
NCT07645651Not Yet Recruiting
Phase 1
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectabl...Carrick Therapeutics Limi...
NCT07643766
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisEnveda TherapeuticsNot Yet RecruitingPhase 2
NCT07643766Not Yet Recruiting
Phase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in...Enveda Therapeutics
NCT07643987
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose ChallengeMethodist Health SystemCompleted
NCT07643987Completed
—
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose ChallengeMethodist Health System
NCT07646041
Annual Brain MRI Surveillance for Detection of Brain Metastasis in Patients With Lung CancerSamsung Medical CenterCompleted
NCT07646041Completed
—
Annual Brain MRI Surveillance for Detection of Brain Metastasis in Patients With...Samsung Medical Center
NCT07645508
Comparison of Conventional, Patient-Specific, and Augmented Reality Navigation in Reverse Total Shoulder ArthroplastyKrankenhaus Barmherzige Schwestern LinzActive Not Recruiting
NCT07645508Active Not Recruiting
—
Comparison of Conventional, Patient-Specific, and Augmented Reality Navigation i...Krankenhaus Barmherzige S...
NCT07645859
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain PatientsDow University of Health SciencesRecruitingNot Applicable
NCT07645859Recruiting
Not Applicable
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuou...Dow University of Health...
NCT07644208
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative HepatectomyShanghai Zhongshan HospitalNot Yet RecruitingPhase 2
NCT07644208Not Yet Recruiting
Phase 2
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatoc...Shanghai Zhongshan Hospit...
NCT07644507
Role of Intraoperative Computed Tomography in Assessment of Spine Instability in Lumbar Degenerative Disease4th Military Clinical Hospital with Polyclinic, PolandNot Yet Recruiting
NCT07644507Not Yet Recruiting
—
Role of Intraoperative Computed Tomography in Assessment of Spine Instability in...4th Military Clinical Hos...
NCT07646145
Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder CancerShanxi Province Cancer HospitalRecruitingPhase 2
NCT07646145Recruiting
Phase 2
Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate-...Shanxi Province Cancer Ho...
NCT07644026
HBV Reactivation Prediction Model in Allo-HSCTInstitute of Hematology & Blood Diseases Hospital, ChinaNot Yet Recruiting
NCT07644026Not Yet Recruiting
—
HBV Reactivation Prediction Model in Allo-HSCTInstitute of Hematology &...
NCT07644962
Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control StrategiesHuashan HospitalNot Yet Recruiting
NCT07644962Not Yet Recruiting
—
Research Project on the Interaction Between Immune Function and Infectious Disea...Huashan Hospital
NCT07644923
Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated CoagulationNYU Langone HealthNot Yet RecruitingPhase 4
NCT07644923Not Yet Recruiting
Phase 4
Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled Wit...NYU Langone Health
NCT07644494
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: The Impact of Spontaneous Respiratory EffortJingyuan,XuCompleted
NCT07644494Completed
—
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: Th...Jingyuan,Xu
NCT07643805
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityNot Yet RecruitingPhase 1
NCT07643805Not Yet Recruiting
Phase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Pat...The First Affiliated Hosp...
NCT07644429
Biomechanical Characterisation of 3D Printed Comfort InsolesUniversity of PecsActive Not RecruitingNot Applicable
NCT07644429Active Not Recruiting
Not Applicable
Biomechanical Characterisation of 3D Printed Comfort InsolesUniversity of Pecs
Result Breakdown
Not yet recruiting10 (50%)
Recruiting4 (20%)
Completed3 (15%)
Active, not recruiting2 (10%)
Enrolling by invitation1 (5%)
Not Specified8 (40%)
Phase 24 (20%)
not_applicable3 (15%)
Phase 42 (10%)
Phase 12 (10%)
Early Phase 11 (5%)